A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

Clinical trial NCT06395909 · COMPLETED

Trial details

NCT number: NCT06395909
Sponsor: Novartis
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis Clinically Isolated Syndrome Relapsing Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis

Start date: 2023-04-23
Primary completion: 2023-08-31
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.